Literature DB >> 27780546

The placental component and obstetric outcome in severe preeclampsia with and without HELLP syndrome.

Eran Weiner1, Letizia Schreiber2, Ehud Grinstein3, Ohad Feldstein3, Noa Rymer-Haskel3, Jacob Bar3, Michal Kovo3.   

Abstract

OBJECTIVE: We aimed to compare obstetric outcome and placental-histopathology in pregnancies complicated by preeclampsia with severe features with and without HELLP syndrome.
METHODS: Labor, maternal characteristics, neonatal outcome and placental histopathology of pregnancies complicated with severe preeclampsia during 2008-2015 were reviewed. Results were compared between those without signs of HELLP syndrome (severe preeclampsia group) and those with concomitant HELLP syndrome (HELLP group). Placental lesions were classified to maternal vascular lesions consistent with malperfusion, fetal vascular lesions consistent with fetal thrombo-occlusive disease, and inflammatory lesions. Small-for-gestational-age (SGA) was defined as birth-weight ≤10th% and ≤5th%. Composite adverse neonatal outcome was defined as one or more early neonatal complications.
RESULTS: Compared to the severe preeclampsia group (n = 223), the HELLP group (n = 64) was characterized by earlier gestational-age, 34.1 ± 2.7 vs. 35.3 ± 3.4 weeks, p = 0.010, higher rates of multiple pregnancies (p = 0.024), and thrombophilia (p = 0.028). Placentas in the HELLP group had higher rates of vascular and villous lesions consistent with maternal malperfusion (p = 0.023, p = 0.037 respectively). By multivariate logistic regression analysis models, vascular and villous lesions of maternal malperfusion were independently associated with HELLP syndrome (aOR 1.9, aOR 1.8, respectively). SGA was also more common in the HELLP group, both below the 10th percentile (p = 0.044) and the 5th percentile (p = 0.016). Composite adverse neonatal outcome did not differ between the groups.
CONCLUSION: Severe preeclampsia and HELLP syndrome have similar placental histopathologic findings. However, HELLP syndrome is associated with higher rates of placental maternal vascular supply lesions and SGA suggesting that the two clinical presentations share a common etiopathogenesis, with higher placental dysfunction in HELLP syndrome.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HELLP syndrome; Malperfusion lesions; Neonatal outcome; Placental histopathology; Placental weight; Severe preeclampsia; Small for gestational age

Mesh:

Year:  2016        PMID: 27780546     DOI: 10.1016/j.placenta.2016.09.012

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  11 in total

1.  Impairment of BKca channels in human placental chorionic plate arteries is potentially relevant to the development of preeclampsia.

Authors:  Mengzhou He; Fanfan Li; Meitao Yang; Yao Fan; Rajluxmee Beejadhursing; Yin Xie; Yuan Zhou; Dongrui Deng
Journal:  Hypertens Res       Date:  2017-11-16       Impact factor: 3.872

2.  Maternal use of selective serotonin reuptake inhibitors (SSRI) during pregnancy-neonatal outcomes in correlation with placental histopathology.

Authors:  Michal Levy; Michal Kovo; Hadas Miremberg; Noa Anchel; Hadas Ganer Herman; Jacob Bar; Letizia Schreiber; Eran Weiner
Journal:  J Perinatol       Date:  2020-01-27       Impact factor: 2.521

3.  Modulation by antenatal therapies of cardiovascular and renal programming in male and female offspring of preeclamptic rats.

Authors:  Yasser H Habib; Mennatallah A Gowayed; Sherien A Abdelhady; Nevine M El-Deeb; Inas E Darwish; Mahmoud M El-Mas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-09-01       Impact factor: 3.195

4.  Placental Histopathology and Pregnancy Outcomes in "Early" vs. "Late" Placental Abruption.

Authors:  Noa Gonen; Michal Levy; Michal Kovo; Letizia Schreiber; Lilach Kornblit Noy; Eldar Volpert; Jacob Bar; Eran Weiner
Journal:  Reprod Sci       Date:  2020-08-18       Impact factor: 3.060

5.  Placental pathology in pregnancies complicated by fetal growth restriction: recurrence vs. new onset.

Authors:  Michal Levy; David Alberti; Michal Kovo; Letizia Schreiber; Eldar Volpert; Liron Koren; Jacob Bar; Eran Weiner
Journal:  Arch Gynecol Obstet       Date:  2020-04-24       Impact factor: 2.344

Review 6.  Mechanistic Insight into Long Noncoding RNAs and the Placenta.

Authors:  Dale McAninch; Claire T Roberts; Tina Bianco-Miotto
Journal:  Int J Mol Sci       Date:  2017-06-27       Impact factor: 5.923

Review 7.  Innate and Adaptive Immune Responses in HELLP Syndrome.

Authors:  Violeta Stojanovska; Ana Claudia Zenclussen
Journal:  Front Immunol       Date:  2020-04-15       Impact factor: 7.561

8.  Management and perinatal outcomes of hypertensive disorders of pregnancy in a low-resource setting in Indonesia.

Authors:  Kevin Dominique Tjandraprawira; Aria Yusti Kusumah; Azka Yumna Kamilah; Dhini Isti Putri; Mayang Rizky Ananta; Selvi Puspa Sari; Tono Djuwantono; Aviva Petrie
Journal:  SAGE Open Med       Date:  2021-11-23

9.  Association between proteinuria and placental pathology in preeclampsia: A retrospective study.

Authors:  Dominique Suzanne Genest; Dorothée Dal Soglio; Sylvie Girard; Evelyne Rey
Journal:  SAGE Open Med       Date:  2021-11-23

10.  Analysis of perinatal coagulation function in preeclampsia.

Authors:  Chang Xu; YunHui Li; Wen Zhang; QiuShi Wang
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.